Cannabis Suisse Corp (CSUI) is an international cannabis company trading on the OTC. The stock is currently priced at $0.0077 with a market capitalization of $544.2K and trailing twelve-month revenue of $21.0K. The company reports a gross margin of -8.9%. View SEC filings ↗
Market Cap
$544.2K
Volume
0
Prev Close
$0.0077
52W High
$0.0154
52W Low
$0.0028
P/S Ratio
25.92
Shares Out
70.7M
Revenue
$21.0K
Gross Margin
-8.9%
Cash
$256.00
CSUI Price Chart
Latest Quarterly Results
In Q3 2026, Cannabis Suisse Corp reported revenue of $21.0K. Gross margin was -4.4%. Net income was $55.1K. The company ended the quarter with $256 in cash and $2.3M of debt.
| CSUI | Q3 2026 | YoY |
|---|---|---|
| Revenue | $21.0K | — |
| Gross margin | -4.4% | — |
| Net income | $55.1K | +296.4% |
| Operating cash flow | $12.8K | — |
| Cash & equivalents | $256 | -16.1% |
| Total debt | $2.3M | +11.6% |
Source: SEC filings, in USD; quarters are calendar quarters of the period end. Latest filing: 10-Q, filed Oct 15, 2026 ↗. Next report expected around Jan 20, 2027 (estimate).
Trading Data
Valuation Metrics
Financial Highlights
View Full FinancialsQuarterly Revenue
Reported quarterly revenue (SEC filings)
TTM: $21.0K
CSUI Key Takeaways
- Cannabis Suisse Corp (CSUI) trades at $0.0077 with a market cap of $544.2K, ranking #68 among 71 cannabis stocks.
- Trailing twelve-month revenue is $21.0K, growing +40.00% year-over-year.
- Gross margin stands at -8.9% — thin margins indicating cost pressures.
- Balance sheet shows $256.00 cash against $2.3M debt — net debt position.
- Price-to-Sales ratio of 25.92x — premium valuation relative to sector.
- Ranked #4 by market cap in the International sector. Trades on the OTC exchange.
CSUI Stock Analysis
Cannabis Suisse Corp (CSUI) is an international cannabis company listed on the OTC exchange, headquartered in CH. With a current share price of $0.0077 and a market capitalization of $544.2K, CSUI ranks #68 out of 71 publicly traded cannabis stocks tracked on Cannabismarketcap.
From a fundamental perspective, Cannabis Suisse Corp reports trailing twelve-month revenue of $21.0K, representing growth of +40.00% year-over-year. The company maintains a gross margin of -8.9%, which reflects the cost pressures common to emerging cannabis operators. At a price-to-sales multiple of 25.92x, the stock carries a premium valuation that prices in significant growth expectations.
The company's balance sheet shows $256.00 in cash and equivalents against $2.3M in total debt, leaving net debt of $2.3M. At the current burn rate, estimated cash runway is approximately 0 months. Investors looking for a deeper dive can explore CSUI's full financial statements including quarterly breakdowns and balance sheet history.
CSUI currently trades within a 52-week range of $0.0028 to $0.0154.
Corporate Information
Share Structure
CSUI Price History
Investment Snapshot
Programmatic analysis based on available financial data. Not investment advice.
Ranked #68 of 71 by market cap ($544.2K). Sector median: $32.9M.
Net debt: $2.3M ($256 cash, $2.3M debt). Gross margin at -8.9%.
Revenue growth at +40.0% YoY. Sector median: +1.6%.
P/S ratio of 25.92x vs sector median of 0.71x. Premium valuation — high expectations priced in.
Cannabis Industry Context
Cannabis Industry Overview
The global cannabis market extends well beyond North America, with an increasing number of countries establishing medical cannabis programs and, in some cases, moving toward regulated adult-use frameworks. Germany has emerged as the largest medical cannabis market in Europe and is pursuing a landmark recreational legalization model that could set precedent for the broader European Union. Other European markets with active medical cannabis programs include Poland, the Czech Republic, Italy, Portugal, and the United Kingdom. In the Asia-Pacific region, Australia and Thailand have developed distinct regulatory approaches, with Thailand becoming the first Southeast Asian country to decriminalize cannabis. Latin American markets — particularly Colombia, Uruguay, and Mexico — offer low-cost cultivation environments and varying degrees of legal market structure. International cannabis companies navigate a complex web of country-specific regulations, EU-GMP certification requirements, import/export licensing, and currency risk. Investors in this segment evaluate geographic diversification, regulatory moat in early-mover markets, supply agreements with established healthcare distributors, and the timeline for market maturation in each jurisdiction.
Cannabis Suisse Corp in the International Cannabis Landscape
Cannabis Suisse Corp (CSUI) currently ranks #4 out of 4 publicly traded international cannabis companies by market capitalization, with a market cap of $544.2K. The company reports trailing-twelve-month revenue of $21.0K, placing it below the sector median of $19.5M. The international cannabis sector comprises 4 tracked companies, reflecting the focused competitive landscape within this segment of the cannabis industry.
The top companies in the international cannabis sector by market capitalization are IM Cannabis Corp (IMCC) at $5.1M, Blueberries Medical Corp (BBRRF) at $4.5M, and Akanda Corp (AKAN) at $2.1M. Cannabis Suisse Corp competes within this group for market share, investor attention, and operational scale as the sector continues to mature.
Key Metrics at a Glance
Regulatory & Risk Considerations
All cannabis investors should be aware that federal legalization status in the United States remains uncertain. While cannabis is legal for medical use in the majority of US states and for adult use in a growing number of jurisdictions, it remains classified as a Schedule I controlled substance at the federal level. This creates material legal, financial, and operational risks across the industry. International cannabis operators like Cannabis Suisse Corp must navigate a patchwork of country-specific regulations that can change rapidly as governments refine their cannabis policies. Import/export licensing, EU-GMP certification requirements, and in-country distribution agreements all require significant time and capital investment, with no guarantee of regulatory continuity.
Currency risk is a material consideration for international operators generating revenue across multiple jurisdictions. Political risk also varies significantly by country — regulatory rollbacks, changes in government, or shifts in public sentiment can disrupt market access. Companies operating in emerging cannabis markets may also face challenges around intellectual property protection, local partner reliability, and the development of compliant supply chains in jurisdictions with limited cannabis-specific infrastructure.
Compare CSUI With Peers
Related International Stocks
Frequently Asked Questions
What is Cannabis Suisse Corp's (CSUI) stock price today?▼
Cannabis Suisse Corp (CSUI) stock is currently trading at $0.0077 per share on the OTC exchange. This represents a daily gain of 0.00% ($0.00) from the previous closing price of $0.0077. Over the past 52 weeks, CSUI has traded between a low of $0.0028 and a high of $0.0154, placing the current price at approximately -50% from its annual high. The stock has a market capitalization of $544.2K, making it a notable cannabis companies tracked by Cannabismarketcap. Cannabis Suisse Corp operates in the International sector, serving the broader cannabis industry.
What is Cannabis Suisse Corp's market capitalization?▼
Cannabis Suisse Corp (CSUI) has a current market capitalization of $544.2K, calculated by multiplying its 70.7M shares outstanding by the current stock price of $0.0077. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places Cannabis Suisse Corp among the small-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $2.9M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.
Is Cannabis Suisse Corp profitable?▼
Cannabis Suisse Corp (CSUI) currently reports a gross margin of -8.9%, which means the company loses 8.9 cents of every revenue dollar after direct costs of goods sold. On trailing twelve month revenue of $21.0K, this translates to an estimated gross profit of approximately -$1.9K. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of Cannabis Suisse Corp's financial health.
What is Cannabis Suisse Corp's annual revenue?▼
Cannabis Suisse Corp (CSUI) reports trailing twelve month (TTM) revenue of $21.0K, reflecting the total sales generated by the company over the most recent four quarters. Revenue has changed +40.00% year-over-year, indicating growth momentum relative to the prior period. The current price-to-sales ratio is 25.92x, which means investors are paying $25.92 for every $1 of annual revenue — a premium valuation in the context of the cannabis sector. Revenue is one of the most closely watched metrics for cannabis companies, as many are still scaling operations in a rapidly evolving regulatory environment. View the full income statement and quarterly revenue breakdown on Cannabismarketcap for detailed trend analysis.
What exchange is CSUI listed on?▼
Cannabis Suisse Corp trades under the ticker symbol CSUI on the OTC exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts, though some brokers may charge additional fees for OTC-listed securities. The stock sees average daily trading volume of approximately 0 shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.
What is Cannabis Suisse Corp's gross margin?▼
Cannabis Suisse Corp (CSUI) has a gross margin of -8.9%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. On trailing twelve month revenue of $21.0K, this translates to an estimated gross profit of approximately -$1.9K. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A negative gross margin like Cannabis Suisse Corp's suggests the company is facing challenges in cost management or pricing.
What is CSUI's 52-week trading range?▼
Cannabis Suisse Corp (CSUI) has traded between a 52-week low of $0.0028 and a 52-week high of $0.0154, with the current price of $0.0077 sitting approximately -50% from the annual high. This range represents a spread of $0.0126 (450% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.
What is Cannabis Suisse Corp's cash position and debt level?▼
Cannabis Suisse Corp (CSUI) holds $256 in cash and equivalents on its balance sheet, set against $2.3M in total debt. This gives the company a net debt position of $2.3M. At the current rate of cash usage, the company has an estimated cash runway of approximately 0 months before needing additional financing, which could come from operations, debt, or equity issuance. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.
How many shares outstanding does Cannabis Suisse Corp have?▼
Cannabis Suisse Corp (CSUI) currently has 70.7M shares outstanding, which when multiplied by the current stock price of $0.0077 gives the company its market capitalization of $544.2K. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.
Embed CSUI Widget
Add the CSUI price widget to your website or blog:
<iframe src="https://cannabismarketcap.io/embed/csui" width="320" height="180" frameborder="0" style="border-radius:8px;border:1px solid #415a77"></iframe>Data updates every 2 minutes. Free for non-commercial use.
Disclaimer
The information on this page is provided for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Cannabismarketcap is not a registered broker-dealer or investment advisor. All data, including stock prices, market capitalizations, financial metrics, and analysis for Cannabis Suisse Corp (CSUI), is provided “as is” without warranty of any kind. Past performance does not guarantee future results. Cannabis stocks are highly volatile and carry significant risk, including the potential for total loss of investment. Marijuana remains illegal under federal law in the United States. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions. Data may be delayed or inaccurate. See our terms of service and privacy policy for more information.